Members

Dr. Gang Liu
Bill & Melinda Gates Foundation

Dr. Elizabeth A. Winzeler
Winzeler Lab at the University of California, San Diego

Dr. Brice Campo
Medicines for Malaria Venture (MMV)

Dr. Dyann F. Wirth
Wirth Lab at Harvard T.H. Chan School of Public Health

Dr. David Fidock
Fidock Lab at Columbia University Irving Medical Center

Dr. Daniel Goldberg
Goldberg Lab at Washington University

Dr. Javier Gamo
GlaxoSmithKline

Dr. Marcus Lee
Lee Lab at Wellcome Sanger Institute

Prof. Jacquin C. Niles
Niles Lab at Massachusetts Institute of Technology

Dr. Nobutaka Kato
The Global Health Drug Discovery Institute

Prof. Ian Gilbert
Wellcome Centre for Anti-Infectives Research (WCAIR), at the University of Dundee

Prof. Manuel Llinás
Llinas Lab at Pennsylvania State University

Prof. Kelly Chibale
Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town

Dr. Koen Dechering
TropIQ Health Sciences

Dr. Case McNamara
Calibr-Skaggs Institute for Innovative Medicines

Dr. Philip Hipskind
Lgenia

Dr. Thierry Diagana
Novartis Institutes for Biomedical Research
News & Announcements
Read the latest news and announcements from the Malaria Drug Accelerator Consortium and related members.
Read More

Phenotype Database
Single nucleotide variants (SNVs) and insertion-deletion events (INDELs) observed in whole genome analysis from various MalDA’s compound selections with shown antimalarial activity can be access in the phenotype database, including a list of peer-reviewed studies in which the compound was a member.
Learn More
